Odimma Therapeutics (Strasbourg, France) is delighted to announce the transfer of its headquarter into the PH8 business incubator dedicated to health technologies, located at 8, place de l'Hôpital in Strasbourg.
Situated in the city center of Strasbourg, these new offices are very close to the University Hospital of Strasbourg and to the future Medtech pole of the city called Nextmed.
This places the company in the middle of the Med/biotech ecosystem. This strategic transfer will favour interactions with researchers, hospital medical staff and companies already present on this site dedicated to innovation in health.
It will also offer Odimma Therapeutics a better international visibility.
The company maintains its research laboratory at ISIS (Institut de Science et d’Ingénierie Supramoléculaires), a multidisciplinary research institute at the interface between Physics, Chemistry, and Biology located within the university campus of Strasbourg.
To follow our news, you can also connect to our Linkedin page:
www.linkedin.com/company/odimma/